Literature DB >> 19797723

Tamoxifen, antidepressants, and CYP2D6: the conundrum continues.

David Holzman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797723     DOI: 10.1093/jnci/djp366

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.

Authors:  Debra L Barton; Beth I LaVasseur; Jeff A Sloan; Allen N Stawis; Kathleen A Flynn; Missy Dyar; David B Johnson; Pamela J Atherton; Brent Diekmann; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

2.  CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application.

Authors:  Nicole van der Merwe; Christianne S H Bouwens; Rika Pienaar; Lize van der Merwe; Yandiswa Y Yako; Dieter H Geiger; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2012-05-26       Impact factor: 3.584

Review 3.  The Impact of CYP2D6 Genotyping on Tamoxifen Treatment.

Authors:  Roberta Ferraldeschi; William G Newman
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.